Zoetis (ZTS) Other financing activities (2012 - 2026)
Zoetis' (ZTS) quarterly Other financing activities came in at -$3.0 million in Q1 2026, down 200.0% year-on-year from $3.0 million in Q1 2025, and down 50.0% on a QoQ basis from -$2.0 million in Q3 2025.
Zoetis (ZTS) Other financing activities (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 13 years of Other financing activities data on file, last reported at -$3.0 million in Q1 2026.
- On a quarterly basis, Other financing activities fell 200.0% year-over-year to -$3.0 million in Q1 2026; TTM through Mar 2026 was -$5.0 million, a 400.0% decrease from a year earlier, with the FY2025 full-year figure at -$3.0 million, changed N/A from the prior year.
- Other financing activities for Q1 2026 stood at -$3.0 million, down from -$2.0 million in the prior quarter.
- Over the last five years, Other financing activities for ZTS reached as high as -$1.0 million in Q1 2025 and fell as low as -$30.0 million in Q1 2022.
- Historically, Other financing activities has averaged -$9.0 million across 3 years, with a median of -$2.5 million in 2025.
- Across the five-year window, Other financing activities rose 23.08% in 2022 and slumped 200.0% in 2026, its largest moves.
- Year by year, Other financing activities stood at -$30.0 million in 2022, then surged by 93.33% to -$2.0 million in 2025, then slumped by 50.0% to -$3.0 million in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were -$3.0 million in Q1 2026, -$2.0 million in Q3 2025, and -$1.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.00 Mn |
| Mar 31, 2026 | -3.00 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Mar 31, 2022 | -30.00 Mn |
| Mar 31, 2022 | -30.00 Mn |
| Jun 30, 2021 | 39.00 Mn |
| Jun 30, 2021 | 39.00 Mn |
| Mar 31, 2021 | -39.00 Mn |
| Mar 31, 2021 | -39.00 Mn |
| Dec 31, 2020 | -20.00 Mn |
| Dec 31, 2020 | -20.00 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Jun 30, 2020 | 4.00 Mn |
| Jun 30, 2020 | 4.00 Mn |
| Mar 31, 2020 | 17.00 Mn |
| Mar 31, 2020 | 17.00 Mn |